Cargando…

Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis

BACKGROUND: Growing evidence has demonstrated that patients undergoing peritoneal dialysis (PD) are more likely to experience cognitive impairment than patients with non-dialysis end-stage renal disease (ESRD); however, the underlying mechanisms remain unclear. This study aimed to identify the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingjing, Wu, Siyang, Zhang, Jin, Li, Yuanyuan, Wu, Yonggui, Qi, Xiangming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696889/
http://dx.doi.org/10.1186/s12882-023-03410-z
_version_ 1785154668572180480
author Wang, Jingjing
Wu, Siyang
Zhang, Jin
Li, Yuanyuan
Wu, Yonggui
Qi, Xiangming
author_facet Wang, Jingjing
Wu, Siyang
Zhang, Jin
Li, Yuanyuan
Wu, Yonggui
Qi, Xiangming
author_sort Wang, Jingjing
collection PubMed
description BACKGROUND: Growing evidence has demonstrated that patients undergoing peritoneal dialysis (PD) are more likely to experience cognitive impairment than patients with non-dialysis end-stage renal disease (ESRD); however, the underlying mechanisms remain unclear. This study aimed to identify the role and predictive significance of gut microbiome alterations in PD-associated cognitive impairment. METHODS: A total of 29 non-dialysis ESRD patients and 28 PD patients were enrolled in this study and divided into subgroups according to the Montreal Cognitive Assessment (MoCA). Faecal samples were analyzed using 16 S rRNA. Mini-Mental State Examination (MMSE) and MoCA scores were used to assess the degree of cognitive impairment in patients. RESULTS: The 16 S rRNA analysis demonstrated differences in gut microbiome abundance and structure between PD and non-dialysis ESRD patients and between PD patients with cognitive impairment (PCI) and PD patients with normal cognition (PNCI). At family and genus levels, Prevotellaceae exhibited the greatest structure difference, while Lactobacillus exhibited the greatest abundance difference between PCI and PNCI. Altered microbiota abundance significantly correlated with cognitive function and serum indicators in PD. In addition, different modules related to fatty acid, lipid, pantothenate, and coenzyme A biosynthesis, and tyrosine and tryptophan metabolism were inferred from 16 S rRNA data between PCI and PNCI. Both groups could be distinguished using models based on the abundance of Lactobacillaceae (Area under curve [AUC] = 0.83), Actinomycetaceae (AUC = 0.798), and Prevotellaceae (AUC = 0.778) families and Lactobacillus (AUC = 0.848) and Actinomyces (AUC = 0.798) genera. CONCLUSION: Gut microbiome evaluation could aid early cognitive impairment diagnosis in patients undergoing PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03410-z.
format Online
Article
Text
id pubmed-10696889
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106968892023-12-06 Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis Wang, Jingjing Wu, Siyang Zhang, Jin Li, Yuanyuan Wu, Yonggui Qi, Xiangming BMC Nephrol Research BACKGROUND: Growing evidence has demonstrated that patients undergoing peritoneal dialysis (PD) are more likely to experience cognitive impairment than patients with non-dialysis end-stage renal disease (ESRD); however, the underlying mechanisms remain unclear. This study aimed to identify the role and predictive significance of gut microbiome alterations in PD-associated cognitive impairment. METHODS: A total of 29 non-dialysis ESRD patients and 28 PD patients were enrolled in this study and divided into subgroups according to the Montreal Cognitive Assessment (MoCA). Faecal samples were analyzed using 16 S rRNA. Mini-Mental State Examination (MMSE) and MoCA scores were used to assess the degree of cognitive impairment in patients. RESULTS: The 16 S rRNA analysis demonstrated differences in gut microbiome abundance and structure between PD and non-dialysis ESRD patients and between PD patients with cognitive impairment (PCI) and PD patients with normal cognition (PNCI). At family and genus levels, Prevotellaceae exhibited the greatest structure difference, while Lactobacillus exhibited the greatest abundance difference between PCI and PNCI. Altered microbiota abundance significantly correlated with cognitive function and serum indicators in PD. In addition, different modules related to fatty acid, lipid, pantothenate, and coenzyme A biosynthesis, and tyrosine and tryptophan metabolism were inferred from 16 S rRNA data between PCI and PNCI. Both groups could be distinguished using models based on the abundance of Lactobacillaceae (Area under curve [AUC] = 0.83), Actinomycetaceae (AUC = 0.798), and Prevotellaceae (AUC = 0.778) families and Lactobacillus (AUC = 0.848) and Actinomyces (AUC = 0.798) genera. CONCLUSION: Gut microbiome evaluation could aid early cognitive impairment diagnosis in patients undergoing PD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-023-03410-z. BioMed Central 2023-12-05 /pmc/articles/PMC10696889/ http://dx.doi.org/10.1186/s12882-023-03410-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Jingjing
Wu, Siyang
Zhang, Jin
Li, Yuanyuan
Wu, Yonggui
Qi, Xiangming
Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
title Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
title_full Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
title_fullStr Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
title_full_unstemmed Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
title_short Correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
title_sort correlation between gut microbiome and cognitive impairment in patients undergoing peritoneal dialysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696889/
http://dx.doi.org/10.1186/s12882-023-03410-z
work_keys_str_mv AT wangjingjing correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis
AT wusiyang correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis
AT zhangjin correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis
AT liyuanyuan correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis
AT wuyonggui correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis
AT qixiangming correlationbetweengutmicrobiomeandcognitiveimpairmentinpatientsundergoingperitonealdialysis